| Home  |  About  |  President's Office  

Office of the President

Marvin SamsonMarvin Samson assumes the role of interim president following the departure of Dr. Helen Giles-Gee in December 2014. Samson has been a committed advocate of University of the Sciences since joining its board of trustees in 1991. He has served as chairman of USciences’ board of trustees since 2011 and was the University’s interim president for the 2011-12 academic year.

Samson is the founder and CEO of Samson Medical Technologies, LLC, a company specializing in injectable drug delivery systems and programs for hospital and alternate site pharmacists. A native of Philadelphia, Samson received his bachelor of science in chemistry from Temple University.

In 1967, Samson helped to found Elkins-Sinn, today, West-Ward Pharmaceuticals, and was its president and CEO for 18 years. Following that, he was the founder, president, and CEO of Marsam Pharmaceuticals; joined SICOR as president and CEO and following Sicor’s acquisition by Teva was Teva’s group VP of worldwide injectables; was board chairman and CEO of Qualitest Pharmaceuticals; and was board chairman of JHP Pharmaceuticals.

Samson holds five U.S. patents pertaining to pharmaceutical manufacturing. He also is active on numerous charitable and industry boards. He is a member of the board of directors of Virtua Health System, NanoPass Technologies, Flynn Pharma, The Franklin Institute, Cooper Rowan Medical School, and Antares Pharma Inc.

A recipient of various awards for business leadership, Samson continues to serve the community through charitable support of educational institutions, hospitals, healthcare research and development, and children’s programs. A resident of Palm Beach, FL, Samson has three children and seven grandchildren.

President's Commission on Sustainability
© 2014 University of the Sciences in Philadelphia • 600 South 43rd Street • Philadelphia, PA 19104 • 215.596.8800
Web site Powered by ActiveCampus™ Software by Datatel, Inc.